SEC Filing | Abbott Laboratories

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Chen Thomas F

(Last)

(First)

(Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK

60064-6400

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/24/2006

3. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Senior Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common shares without par value	57,140	D
Common shares without par value	16,708⁽¹⁾	I	Profit Sharing Trust
Common shares without par value	23,798⁽²⁾	I	By wife
Common shares without par value	2,476⁽²⁾	I	By self for daughter

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option (right to buy)⁽³⁾	02/12/2002	02/11/2009	Common shares	40,433	42.4978	D
Option (right to buy)⁽³⁾	01/18/2001	02/13/2007	Common shares	5,137	39.716	D
Option (right to buy)⁽³⁾	05/21/2001	02/12/2008	Common shares	15,202	49.4617	D
Option (right to buy)⁽³⁾	02/09/2004	02/08/2011	Common shares	53,202	45.4488	D
Option (right to buy)⁽³⁾	06/22/2002	02/10/2010	Common shares	9,686	52.2529	D
Option (right to buy)⁽³⁾	02/15/2005	02/14/2012	Common shares	53,201	53.625	D
Option (right to buy)⁽³⁾	06/03/2003	02/10/2010	Common shares	20,437	41.1445	D
Option (right to buy)⁽³⁾	02/14/2006	02/13/2013	Common shares	3,050	33.2314	D
Option (right to buy)⁽³⁾	12/06/2003	02/10/2010	Common shares	12,804	41.9715	D
Option (right to buy)⁽³⁾	02/20/2006	02/19/2014	Common shares	21,281	41.0317	D
Option (right to buy)⁽³⁾	02/20/2007	02/19/2014	Common shares	10,639	41.0317	D
Option (right to buy)⁽³⁾	10/21/2004	02/13/2013	Common shares	15,585	41.5392	D
Option (right to buy)⁽³⁾	05/10/2005	02/13/2007	Common shares	2,701	44.96	D
Option (right to buy)⁽³⁾	05/10/2005	02/10/2010	Common shares	2,223	44.96	D
Option (right to buy)⁽³⁾	05/10/2005	02/12/2008	Common shares	2,283	44.96	D
Option (right to buy)⁽³⁾	05/10/2005	02/12/2008	Common shares	18,444	44.96	D
Option (right to buy)⁽⁴⁾	02/18/2006	02/17/2015	Common shares	11,600	46.34	D
Option (right to buy)⁽⁴⁾	02/18/2007	02/17/2015	Common shares	11,600	46.34	D
Option (right to buy)⁽⁴⁾	02/18/2008	02/17/2015	Common shares	11,600	46.34	D
Option (right to buy)⁽⁴⁾	11/26/2005	02/13/2013	Common shares	14,418	48.67	D
Option (right to buy)⁽⁴⁾	08/15/2006	02/13/2013	Common shares	12,441	42.83	D
Option (right to buy)⁽⁴⁾	02/17/2007	02/16/2016	Common shares	12,000	44.16	D
Option (right to buy)⁽⁴⁾	02/17/2008	02/16/2016	Common shares	12,000	44.16	D
Option (right to buy)⁽⁴⁾	02/17/2009	02/16/2016	Common shares	12,000	44.16	D

Explanation of Responses:

1. Balance in the Abbott Laboratories Stock Retirement Trust as of April 28, 2006.

2. Reporting person disclaims beneficial ownership of securities held by his wife and daughter.

3. Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

4. Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3.

	John A. Berry by power of attorney for Thomas F. Chen	05/01/2006
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.